Eisai Co. Ltd. | Ownership
Companies that own Eisai Co. Ltd.
Wellington Management Co. LLP
25,598,248
8.63%
0
0.44%
03/31/2018
Nomura Asset Management Co., Ltd.
14,963,100
5.05%
8,888,900
0.77%
03/15/2018
BlackRock Fund Advisors
8,595,500
2.9%
315,143
0.04%
08/15/2017
Nikko Asset Management Co., Ltd.
7,553,599
2.54%
142,999
0.4%
09/03/2018
Daiwa Asset Management Co. Ltd.
6,728,399
2.27%
-144,801
0.7%
07/31/2018
The Vanguard Group, Inc.
6,511,640
2.2%
16,800
0.02%
07/31/2018
BlackRock Japan Co., Ltd.
5,615,000
1.89%
1,770,500
0.66%
08/15/2017
Mitsubishi UFJ Kokusai Asset Management Co., Ltd.
3,815,450
1.29%
53,851
0.74%
07/31/2018
Norges Bank Investment Management
3,040,304
1.02%
-274,434
0.04%
12/31/2017
Credicorp Capital Asset Management SA AGF
1,666,544
0.56%
0
67.84%
06/30/2018
| Address |
4-6-10 Koishikawa
Tokyo Tokyo 112
Japan
|
|
Employees
|
- |
| Website |
http://www.eisai.co.jp |
| Updated |
07/08/2019 |
| Eisai Co., Ltd. engages in the development, manufacture, and sale of prescription medicines and over-the-counter products. It operates through the Pharmaceutical Products Business and Other Business segments. The Pharmaceutical Products Business segment handles prescription and generic drugs, diagnostics, and consumer healthcare business in Japan, which manages over-the-counter drugs. |
